A robust and versatile mass spectrometry platform for comprehensive assessment of the thiol redox metabolome
A robust and versatile mass spectrometry platform for comprehensive assessment of the thiol redox metabolome
Several diseases are associated with perturbations in redox signaling and aberrant hydrogen sulfide metabolism, and numerous analytical methods exist for the measurement of the sulfur-containing species affected. However, uncertainty remains about their concentrations and speciation in cells/biofluids, perhaps in part due to differences in sample processing and detection principles. Using ultrahigh-performance liquid chromatography in combination with electrospray-ionization tandem mass spectrometry we here outline a specific and sensitive platform for the simultaneous measurement of 12 analytes, including total and free thiols, their disulfides and sulfide in complex biological matrices such as blood, saliva and urine. Total assay run time is < 10 min, enabling high-throughput analysis. Enhanced sensitivity and avoidance of artifactual thiol oxidation is achieved by taking advantage of the rapid reaction of sulfhydryl groups with N-ethylmaleimide. We optimized the analytical procedure for detection and separation conditions, linearity and precision including three stable isotope labelled standards. Its versatility for future more comprehensive coverage of the thiol redox metabolome was demonstrated by implementing additional analytes such as methanethiol, N-acetylcysteine, and coenzyme A. Apparent plasma sulfide concentrations were found to vary substantially with sample pretreatment and nature of the alkylating agent. In addition to protein binding in the form of mixed disulfides (S-thiolation) a significant fraction of aminothiols and sulfide appears to be also non-covalently associated with proteins. Methodological accuracy was tested by comparing the plasma redox status of 10 healthy human volunteers to a well-established protocol optimized for reduced/oxidized glutathione. In a proof-of-principle study a deeper analysis of the thiol redox metabolome including free reduced/oxidized as well as bound thiols and sulfide was performed. Additional determination of acid-labile sulfide/thiols was demonstrated in human blood cells, urine and saliva. Using this simplified mass spectrometry-based workflow the thiol redox metabolome can be determined in samples from clinical and translational studies, providing a novel prognostic/diagnostic platform for patient stratification, drug monitoring, and identification of new therapeutic approaches in redox diseases.
359-380
Sutton, T.R.
35814b1d-8f1a-4ca7-b870-c331d99058fc
Minnion, M.
ab23b32b-9f8e-4876-aaf5-99cb6a725a2f
Barbarino, F.
68c578cc-e5ab-4afb-b83b-9fccc0fecd24
Koster, G.
e404c38a-6f48-430a-adf0-5208228cb9e7
Fernandez, B.O.
9890aabc-1fe6-4530-a51e-31182e537131
Cumpstey, Andrew
cd040417-5e62-41d2-8640-1ec8905858a7
Wischmann, P.
8ac53523-a51a-4115-93f3-942fe07fdf50
Madhani, M.
9facf752-474f-46c2-a03b-d4fd966749ce
Frenneaux, M.P.
0212dec4-bb21-40a8-8f02-e4fd5a3750a6
Postle, A.D.
0fa17988-b4a0-4cdc-819a-9ae15c5dad66
Cortese-Krott, M.M.
7dc9b44c-847c-4196-8866-a3cc0c1dc357
Feelisch, M.
8c1b9965-8614-4e85-b2c6-458a2e17eafd
June 2018
Sutton, T.R.
35814b1d-8f1a-4ca7-b870-c331d99058fc
Minnion, M.
ab23b32b-9f8e-4876-aaf5-99cb6a725a2f
Barbarino, F.
68c578cc-e5ab-4afb-b83b-9fccc0fecd24
Koster, G.
e404c38a-6f48-430a-adf0-5208228cb9e7
Fernandez, B.O.
9890aabc-1fe6-4530-a51e-31182e537131
Cumpstey, Andrew
cd040417-5e62-41d2-8640-1ec8905858a7
Wischmann, P.
8ac53523-a51a-4115-93f3-942fe07fdf50
Madhani, M.
9facf752-474f-46c2-a03b-d4fd966749ce
Frenneaux, M.P.
0212dec4-bb21-40a8-8f02-e4fd5a3750a6
Postle, A.D.
0fa17988-b4a0-4cdc-819a-9ae15c5dad66
Cortese-Krott, M.M.
7dc9b44c-847c-4196-8866-a3cc0c1dc357
Feelisch, M.
8c1b9965-8614-4e85-b2c6-458a2e17eafd
Sutton, T.R., Minnion, M., Barbarino, F., Koster, G., Fernandez, B.O., Cumpstey, Andrew, Wischmann, P., Madhani, M., Frenneaux, M.P., Postle, A.D., Cortese-Krott, M.M. and Feelisch, M.
(2018)
A robust and versatile mass spectrometry platform for comprehensive assessment of the thiol redox metabolome.
Redox Biology, 16, .
(doi:10.1016/j.redox.2018.02.012).
Abstract
Several diseases are associated with perturbations in redox signaling and aberrant hydrogen sulfide metabolism, and numerous analytical methods exist for the measurement of the sulfur-containing species affected. However, uncertainty remains about their concentrations and speciation in cells/biofluids, perhaps in part due to differences in sample processing and detection principles. Using ultrahigh-performance liquid chromatography in combination with electrospray-ionization tandem mass spectrometry we here outline a specific and sensitive platform for the simultaneous measurement of 12 analytes, including total and free thiols, their disulfides and sulfide in complex biological matrices such as blood, saliva and urine. Total assay run time is < 10 min, enabling high-throughput analysis. Enhanced sensitivity and avoidance of artifactual thiol oxidation is achieved by taking advantage of the rapid reaction of sulfhydryl groups with N-ethylmaleimide. We optimized the analytical procedure for detection and separation conditions, linearity and precision including three stable isotope labelled standards. Its versatility for future more comprehensive coverage of the thiol redox metabolome was demonstrated by implementing additional analytes such as methanethiol, N-acetylcysteine, and coenzyme A. Apparent plasma sulfide concentrations were found to vary substantially with sample pretreatment and nature of the alkylating agent. In addition to protein binding in the form of mixed disulfides (S-thiolation) a significant fraction of aminothiols and sulfide appears to be also non-covalently associated with proteins. Methodological accuracy was tested by comparing the plasma redox status of 10 healthy human volunteers to a well-established protocol optimized for reduced/oxidized glutathione. In a proof-of-principle study a deeper analysis of the thiol redox metabolome including free reduced/oxidized as well as bound thiols and sulfide was performed. Additional determination of acid-labile sulfide/thiols was demonstrated in human blood cells, urine and saliva. Using this simplified mass spectrometry-based workflow the thiol redox metabolome can be determined in samples from clinical and translational studies, providing a novel prognostic/diagnostic platform for patient stratification, drug monitoring, and identification of new therapeutic approaches in redox diseases.
Text
2018 Sutton Redox Biol
- Version of Record
More information
Accepted/In Press date: 13 February 2018
e-pub ahead of print date: 19 February 2018
Published date: June 2018
Identifiers
Local EPrints ID: 419614
URI: http://eprints.soton.ac.uk/id/eprint/419614
ISSN: 2213-2317
PURE UUID: e994062a-137a-4632-812f-5a524d5559ad
Catalogue record
Date deposited: 16 Apr 2018 16:30
Last modified: 30 Aug 2024 02:05
Export record
Altmetrics
Contributors
Author:
T.R. Sutton
Author:
M. Minnion
Author:
F. Barbarino
Author:
G. Koster
Author:
B.O. Fernandez
Author:
Andrew Cumpstey
Author:
P. Wischmann
Author:
M. Madhani
Author:
M.P. Frenneaux
Author:
M.M. Cortese-Krott
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics